Dashboard
Manage Tickers

CRMD CorMedix Inc.

Nasdaq cormedix.com


$ 11.21 $ -0.45 (-3.86 %)    

Wednesday, 22-Oct-2025 16:00:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 605.23 nm (nm)
DIA $ 465.24 $ -3.44 (-0.73 %)
SPY $ 667.81 nm (nm)
TLT $ 92.17 nm (nm)
GLD $ 377.10 nm (nm)
$ 11.2
$ 11.58
$ 11.01 x 50
$ 11.30 x 200
$ 11.02 - $ 11.72
$ 5.60 - $ 17.43
2,273,917
na
805.49M
$ 1.68
$ 15.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-06-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-12-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-09-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-10-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-16-2020 12-31-2019 10-K
24 11-14-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-13-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-14-2018 09-30-2018 10-Q
29 08-14-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-19-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

beyond-the-numbers-4-analysts-discuss-cormedix-stock
Beyond The Numbers: 4 Analysts Discuss Cor...
10/21/2025 22:01:38

rbc-capital-maintains-outperform-on-cormedix-raises-price-target-to-22
RBC Capital Maintains Outperform on Cormed...
10/21/2025 14:34:57

RBC Capital analyst Leonid Timashev maintains Cormedix (NASDAQ:CRMD) with a Outperform and raises the price target from $21 ...

d-boral-capital-upgrades-cormedix-to-buy-announces-14-price-target
D. Boral Capital Upgrades Cormedix to Buy,...
10/20/2025 13:33:06

D. Boral Capital analyst Jason Kolbert upgrades Cormedix (NASDAQ:CRMD) from Hold to Buy and announces $14 price target.

Core News & Articles
Market-Moving News for October 20th
10/20/2025 11:36:19

REPL: 81% | The FDA Accepts Replimune's Resubmission Of The Biologics License Application For RP1 In Combination With Nivol...

cormedix-sees-q3-unaudited-pro-forma-net-revenue-over-125m-raises-fy-2025-pro-forma-net-revenue-guidance-to-375m
CorMedix Sees Q3 Unaudited Pro Forma Net R...
10/20/2025 11:32:37

cormedix-files-for-offering-of-up-to-63m-shares-of-common-stock-by-selling-securityholders
CorMedix Files For Offering Of Up To 6.3M ...
09/30/2025 21:22:55

https://www.sec.gov/Archives/edgar/data/1410098/000121390025094067/ea0258874-s3_cormedix.htm

cormedix-completes-enrollment-in-phase-iii-respect-trial-for-rezzayo-in-fungal-infection-prevention
CorMedix Completes Enrollment In Phase III...
09/29/2025 13:20:34

- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allo...

analyst-expectations-for-cormedixs-future
Analyst Expectations For Cormedix's Future
09/09/2025 18:01:00

jmp-securities-reiterates-market-outperform-on-cormedix-maintains-22-price-target
JMP Securities Reiterates Market Outperfor...
09/09/2025 12:37:52

JMP Securities analyst Jason N. Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $22 price ta...

Core News & Articles
Talphera Granted CorMedix Exclusive Right ...
09/08/2025 12:37:35

Core News & Articles
CorMedix Makes $5M Minority Investment In ...
09/08/2025 12:31:50

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/02/2025 17:35:29

cormedix-names-susan-blum-cfo-of-melinta-therapeutics-as-evp--chief-financial-officer
CorMedix Names Susan Blum, CFO Of Melinta ...
09/02/2025 11:40:44

Planned Senior LeadershipThe following executives will form the core of the senior leadership team of the newly merged company ...

cormedix-revised-guidance-of-pro-forma-2025-combined-revenues-to-325m-350m-vs-consensus-of-21514m-melinta-therapeutics-deal-expected-to-be-near-term-accretive-to-eps-with-double-digit-accretion-expected-in-2026
CorMedix Revised Guidance Of Pro Forma 202...
09/02/2025 11:39:36

Transaction expected to be near-term accretive to EPS with double-digit accretion expected in 2026; annual run-rate synergies e...

hedge-fund-elliott-managements-q2-moves-include-positions-tied-to-sp-500-nasdaq-nvidia-corrected
Hedge Fund Elliott Management's Q2 Moves I...
08/15/2025 19:42:50

Hedge fund Elliott Management revealed a Q2 portfolio reshuffle, adding new positions tied to major indexes and tech leaders li...

deal-dispatch-performance-food-group-and-claires-lead-a-week-of-big-auctions-retail-woes
Deal Dispatch: Performance Food Group And ...
08/08/2025 20:02:31

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...

hc-wainwright--co-maintains-buy-on-cormedix-lowers-price-target-to-17
HC Wainwright & Co. Maintains Buy on Corme...
08/08/2025 10:16:29

HC Wainwright & Co. analyst Brandon Folkes maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from ...

somnigroup-internationals-cormedix-to-acquire-melinta-in-300m-deal-expanding-infectious-disease-portfolio
Somnigroup International's CorMedix to Acq...
08/07/2025 11:14:42

CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therape...

cormedix-q2-eps-028-beats-015-estimate-sales-3974m-beat-3253m-estimate
Cormedix Q2 EPS $0.28 Beats $0.15 Estimate...
08/07/2025 11:13:18

cormedix-analyst-says-investors-could-be-further-rewarded
CorMedix Analyst Says Investors Could Be F...
06/30/2025 18:24:09

CorMedix boosts Q2 sales forecast as a major dialysis client accelerates DefenCath use, prompting positive analyst coverage and...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION